A detailed history of Israel Englander (Millennium Management LLC) transactions in Pep Gen Inc. stock. As of the latest transaction made, Millennium Management LLC holds 13,822 shares of PEPG stock, worth $17,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,822
Holding current value
$17,830
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.75 - $18.55 $107,120 - $256,398
13,822 New
13,822 $118,000
Q4 2023

Feb 14, 2024

BUY
$3.86 - $7.96 $8,017 - $16,532
2,077 Added 11.71%
19,807 $134,000
Q2 2023

Aug 14, 2023

BUY
$8.94 - $16.39 $65,083 - $119,319
7,280 Added 69.67%
17,730 $158,000
Q1 2023

May 15, 2023

BUY
$11.44 - $17.7 $119,548 - $184,965
10,450 New
10,450 $128,000
Q3 2022

Nov 14, 2022

BUY
$4.86 - $12.75 $734,710 - $1.93 Million
151,175 Added 72.07%
360,941 $3.28 Million

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $30.5M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.